Back to search

Article

Computational design of CYP102A1 variants for the biosynthesis of a next-generation antiplatelet drug DT-678

2025-12-05

Abstract excerpt

Clopidogrel is a widely used antiplatelet prodrug to treat acute coronary syndromes. However, its clinical efficacy is hampered by ineffective bioactivation to produce the pharmacologically active metabolite (AM), leading to variability in antiplatelet response among different ethnic groups. To overcome the shortcomings of clopidogrel, DT-678 was developed by conjugating the AM to 3-nitropyridine-2-thiol via a mix...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c5f0de6-a41b-5426-a0d1-d30ede998602
DOI
10.64898/2025.12.04.692440
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Computational design of CYP102A1 variants for the biosynthesis of a next-generation antiplatelet drug DT-678DOI 10.64898/2025.12.04.692440
Select a neighboring publication to make it the new centre.